British Journal of Haematology 2003: Vol 123 Table of Contents

17 Pages·2003·2.6 MB·English

BRITISH JOURNAL
HAEMATOLOGY
EDITORS: [AN HANN, FINBARR COTTER, JOHN REILLY
ASSOCIATE EDITORS
H. E. Broxmeyer, A. K. Burnett, M. Greaves, M. Y. Gordon,
I. R. Peake, M. J. Pippard, I. A. G. Roberts, N. Russell, S. L. Thein, L. Williamson
EDITORIAL BOARD
I. R. Peake Chairman
R. Auer, T. Baglin, B. J. Bain, M. Barnett, B. Bennett, J. Boultwood, C. Camaschella,
R. Chopra, C. J. Eaves, C. Fegan, P. Fenaux, A. Goodeve, A. R. Green, J. D. Griffin,
H. Heslop, T. L. Holyoake, M. Le Beau, D. Linch, M. Makris, C. Mecucci, D. R. Miller,
P. A. H. Moss, A. Nurden, D. Provan, D. Pamphilon, D. Rees, D. Rund, O. P. Smith,
M. Worwood
Volume 123
Pages 1-968
Dy
Blackwell
Publishing
2003
© 2003 British Journal of Haematology Blackwell Publishing Ltd
Published by Blackwell Publishing Ltd
Editorial Offices:
Blackwell Publishing Ltd, 101 George Street, Edinburgh EH2 3ES, UK
Blackwell Publishing Ltd, 9600 Garsington Road, Oxford OX4 2DQ, UK
Blackwell Publishing Asia Pty, 550 Swanston Street, Carlton South, Melbourne, VIC 3053, Australia, and TK Building, 2-38-14 Hongo,
Bunkyo-ku, Tokyo 113-0033, Japan
Blackwell Publishing Europe Ltd, 10 rue Casimir Delavigne, F-75006 Paris, France
Blackwell Verlag GmgH, Kurfiirstendamm 57, D-10707 Berlin, Germany
Blackwell Publishing KK, NK Building 3F, 2-8—12 Iwamotocho, Chiyodaku, Tokyo 101-0032, Japan
Blackwell Publishing Inc, Commerce Place, 350 Main Street, Malden, MA 02148-5018, USA
Blackwell Munksgaard, 1, Rosenorns Alle, P.O. Box 227, DK-1502 Copenhagen V, Denmark
Authorization to photocopy items for internal or personal use is granted by the copyright holder for libraries and other users of the Copyright
Clearance Center (CCC), 222 Rosewood Drive, Danvers, MA 01923, USA (www.copyright.com), provided the appropriate fee is paid directly to
the CCC. This consent does not extend to other kinds of copying, such as copying for general distribution, for advertising or promotional
purposes, for creating new collective works or for resale.
British Journal of Haematology is covered by ADONIS, ASCA, Chemical Abstracts, Current Awareness in Biological Sciences, Current Contents, Current
Clinical Cancer, Index Medicus, ISI/BIOMED, and Science Citation Index.
ISSN 0007-1048
Typeset by Scientific Publishing Services, India, and printed by the Alden Group, Oxford.
Volume Contents
BRITISH JOURNAL OF HAEMATOLOGY
Volume 123, Issue 1, October-I 2003
IMAGES IN HAEMATOLOGY
Pulmonary veno-occlusive disease following allogeneic peripheral blood stem cell
transplantation for chronic myeloid leukaemia
M. Mukai, M. Kondo, T. Bohgaki, A. Notoya and M. Kohno
Circulating neuroblastoma cells in peripheral blood
V. Moodley and R. Pool
HISTORICAL REVIEWS
William Osler’s legacy and his contribution to haematology
M. J. Stone
Paul Ehrlich’s doctoral thesis: a milestone in the study of mast cells
E. Crivellato, C. A. Beltrami, F. Mallardi and D. Ribatti
GUIDELINE
Guidelines on the use of colony-stimulating factors in haematological malignancies
A. Pagliuca, P. A. Carrington, R. Pettengell, S. Rule and J. Keidan on behalf of the
Haemato-Oncology Task Force of the British Committefeo r Standards in Haematology
HAEMATOLOGICAL MALIGNANCY
Ber-Abl upregulates cytosolic p21”“*'/C” “! by a phosphoinositide-3-kinase
(PI3K)-independent pathway
K. Keeshan, T. G. Cotter and S. L. McKenna
Role of DNA mismatch repair genetic polymorphisms in the risk of childhood
acute lymphoblastic leukaemia
G. Mathonnet, M. Krajinovic, D. Labuda and D. Sinnett
Prognostic significance of quantitative analysis of WT1 gene transcripts by
competitive reverse transcription polymerase chain reaction in acute leukaemia
M. Garg, H. Moore, K. Tobal and J. A. L. Yin
Geographical and ecological analyses of childhood acute leukaemias and
lymphomas in north-west England
R. J. Q. McNally, R. D. Alston, D. P. Cairns, O. B. Eden and J. M. Birch
The P2X7 receptor gene polymorphism 1513 A — C has no effect on clinical
prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein
expression or survival in B-cell chronic lymphocytic leukaemia
J. Starczynski, C. Pepper, G. Pratt, L. Hooper, A. Thomas, T. Hoy, D. Milligan,
P. Bentley and C. Fegan
Volume Contents
Elevated levels of cyclin Al and A (A2) mRNA in acute myeloid leukaemia are
associated with increased survival
T. Nakamaki, Y. Hamano, J.-I. Hisatake, A. Yokoyama, K.-I. Kawakami, S. Tomoyasu,
Y. Honma and P. Koeffler
The impact of intensive antileukaemic treatment strategies on prognosis of
myelodysplastic syndrome patients aged less than 61 years according to
International Prognostic Scoring System risk groups
M. Oosterveld, S. H. Wittebol, W. A. J. G. Lemmens, B. A. L. M. Kiemeney, A. Catik,
P. Muus, A. V. M. B. Schattenberg and T. J. M. de Witte
Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-
Hodgkin’s lymphoma
S. Guyomard, G. Salles, M. Coudurier, H. Rousset, B. Coiffier, J. Bienvenu and N. Fabien
Short reports 100 Veno-occlusive disease in patients receiving thiopurines during maintenance
therapy for childhood acute lymphoblastic leukaemia
S. Stoneham, L. Lennard, P. Coen, J. Lilleyman and V. Saha
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human
erythropoietin therapy given between first and second HDT allows second
peripheral blood stem cell transplantation without red blood cell transfusion
F. Baron, P. Frere, G. Fillet and Y. Beguin
Serum levels of macrophage inflammatory protein-1 alpha (MIP-1«) correlate
with the extent of bone disease and survival in patients with multiple myeloma
E. Terpos, M. Politou, R. Szydlo, J. M. Goldman, J. F. Apperley and A. Rahemtulla
TRANSPLANTATION
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin
inhibitor-induced neurotoxicity
R. Chohan, R. Vij, D. Adkins, W. Blum, R. Brown, M. Tomasson, S. Devine,
T. Graubert, L. T. Goodnough, J. F. DiPersio and H. Khoury
The use of stimulated granulocyte transfusions to prevent recurrence of past
severe infections after allogeneic stem cell transplantation
J. P. Kerr, E. Liakopolou, J. Brown, J. M. Cornish, D. Fleming, E. Massey, A. Oakhill,
D. H. Pamphilon, S. P. Robinson, A. Totem, A. M. P. I. Valencia and D. I. Marks
Phenotype, function and chimaerism of monocyte-derived blood dendritic cells
after allogeneic haematopoietic stem cell transplantation
D. Nachbaur, B. Kircher, K. Eisendle, K. Latzer, M. Haun and G. Gastl
PLATELETS, HAEMOSTASIS AND THROMBOSIS
Bernard-—Soulier syndrome due to the homozygous Asn-45Ser mutation in GPIX:
an unexpected, frequent finding in Germany
U. J. H. Sachs, H. Kroll, A. C. Matzdorff, H. Berghdfer, J. A. Lépez and S. Santoso
Molecular, ultrastructural and functional characterization of a Spanish family
with Hermansky—Pudlak syndrome: role of insC974 in platelet function and
clinical relevance
R. Gonzalez-Conejero, J. Rivera, G. Escolar, I. Zuazu-Jausoro, V. Vicente and J. Corral
Short reports 139 Beta-adrenergic receptor polymorphisms in patients with elevated factor VIII levels
with venous thrombosis
J. O'Donnell, R. A. Manning and M. A. Laffan
Volume Contents Vv
Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP)
during pregnancy
M. Michel, M. V. Novoa and J. B. Bussel
RED CELLS AND IRON
Pure red cell aplasia associated with expansion of CD3* CD8* granular
lymphocytes expressing cytotoxicity against HLA-E” cells
K. L. Mori, H. Furukawa, K. Hayashi, K.-J]. J. Sugimoto and K. Oshimi
A novel deletion causing (ey5p)° thalassaemia in a Chilean family
L. Game, J. Bergounioux, J. P. Close, B. E. Marzouka and S. L. Thein
Quiescent CD34" early erythroid progenitors are resistant to several erythro-
poietic ‘inhibitory’ cytokines; role of FLIP
J. Ratajczak, M. Kucia, R. Reca, J. Zhang, B. Machalinski and M. Z. Ratajczak
Short reports Hypoxic response of iron absorption is not affected by the Hfe gene knock-out in mice
A. H. Laftah, R. J. Simpson, N. Beaumont, 8. Bahram, K. Schtimann and S. K. S. Srai
Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually
occur in haematopoietic cells that are glycosylphosphatidylinositol-anchored
protein (GPI-AP) positive
E. M. Sloand, M. Fuhrer, K. Keyvanfar, L. Mainwaring, J. Maciejewski, Y. Wang.
S. Johnson, A. J. Barrett and N. S. Young
HAEMOPOIESIS AND LEUCOCYTES
The type 1 CD10/neutral endopeptidase 24.11 promoter: functional character-
ization of the 5’-untranslated region
N. Sezaki, F. Ishimaru, T. Tabayashi, I. Kataoka, K. Nakase, K. Fujii, T. Kozuka,
H. Nakayama, M. Harada and M. Tanimoto
CORRESPONDENCE
Paediatric myelodysplasia
M. M. Reid
Paediatric myelodysplasia — response to M. M. Reid
S. J. Passmore, C. A. Stiller, H. Kempski and I. M. Hann
ERRATA
BOOK REVIEWS
ANNOUNCEMENT
Volume 123,> Issue 2, October-II 2003
IMAGES IN HAEMATOLOGY
Malignant sarcoma masquerading as a pseudotumour in a patient with mild
haemophilia
P. Connor, B. Cheung and S. Rangarajan
192 Atypical large granular lymphocytes in a child
F. Girodon, L. Faivre, N. Devillier, P. M. Carli and M. Maynadie
Volume Contents
REVIEW
The role of haploidentical stem cell transplantation in the management of children
with haematological disorders
P. Veys, P. Amrolia and K. Rao
HISTORICAL REVIEW
Haematology at the Hammersmith hospital and Royal Postgraduate Medical
School 1934-1994
A. V. Hoffbrand
HAEMATOLOGICAL MALIGNANCY
Cytogenetic findings in adult de novo acute myeloid leukaemia. A population-based
study of 303/337 patients
B. S. Preiss, G. B. Kerndrup, K. G. Schmidt, A. G. Sorensen, N.-A. T. Clausen,
O. V. Gadeberg, T. Mourits-Andersen and N. T. Pedersen on behalf of the AML study
Group Region of Southern Denmark
Possible regulation of Wilms’ tumour gene 1 (WT1) expression by the paired box
genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in
human acute myeloid leukaemias
J. M. Siehl, E. Thiel, K. Heufelder, E. Snarski, S. Schwartz, V. Maildnder and U. Keilholz
Clinical significance of residual disease during treatment in childhood acute
myeloid leukaemia
E. Coustan-Smith, R. C. Ribeiro, J. E. Rubnitz, B. I. Razzouk, C.-H. Pui, 8. Pounds,
M. Andreansky, F. G. Behm, S. C. Raimondi, S. A. Shurtleff, J. R. Downing and
D. Campana
Occurrence of dysregulated oncogenes in primary plasma cells representing
consecutive stages of myeloma pathogenesis: indications for different disease
entities
T. Rasmussen, K. Theilgaard-Monch, H. R. Hudlebusch, M. Lodahl, H. E. Johnsen and
I. M. S. Dahl
Enhanced production of ostecpontin in multiple myeloma: clinical and pathogenic
implications
Y. Saeki, T. Mima, T. Ishii, A. Ogata, H. Kobayashi, S. Ohshima, T. Ishida, Y. Tabunoki,
H. Kitayama, M. Mizuki, Y. Katada, H. Asaoku, M. Kitano, N. Nishimoto, K. Yoshizaki,
M. Maeda, S. Kon, N. Kinoshita, T. Uede and I. Kawase
Chlorambucil in combination with induction and maintenance rituximab is
feasible and active in indolent non-Hodgkin's lymphoma
G. Martinelli, D. Laszlo, F. Bertolini, R. Pastano, P. Mancuso, A. Calleri, A. Vanazzi,
P. Santoro, F. Cavalli and E. Zucca
Successful treatment of refractory pure red cell aplasia associated with lympho-
proliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab
(Campath-1H)
X. Ru and H. A. Liebman
Predictive value of early '*F-fluoro-deoxyglucose positron emission tomography in
chemosensitive relapsed lymphoma
B. Schot, G. van Imhoff, J. Pruim, W. Sluiter, W. Vaalburg and E. Vellenga
Volume Contents Vii
DNA microarray analysis of stage progression mechanism in myelodysplastic
syndrome
M. Ueda, J. Ota, Y. Yamashita, Y. L. Choi, R. Ohki, T. Wada, K. Koinuma, Y. Kano,
K. Ozawa and H. Mano
Granulomatous slack skin disease — disease features and response to pentostatin
N. Osuji, L. Fearfield, E. Matutes, A. C. Wotherspoon, C. Bunker and D. Catovsky
Short report Plasma levels of tumour necrosis factor alpha and interleukin-6 predict
progression-free survival following thalidomide therapy in patients with
previously untreated multiple myeloma
M. A. Thompson, T. E. Witzig, S. Kumar, M. M. Timm, J. Haug, R. Fonseca, P. R. Greipp,
J. A. Lust and S. V. Rajkumar
TRANSPLANTATION
T- and B-cell immune reconstitution and clinical outcome in patients with
multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell
transplantation with an alemtuzumab-containing conditioning regimen followed
by escalated donor lymphocyte infusions
S. D’Sa, K. Peggs, A. Pizzey, S. Verfuerth, D. Thuraisundaram, M. Watts, H. White,
G. Hale, H. Waldmann, A. Goldstone, S. Mackinnon and K. Yong
Short report T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-
depleted HLA-non-identical paediatric bone marrow transplantation
E. J. Lowe, V. Turner, R. Handgretinger, E. M. Horwitz, E. Benaim, G. A. Hale,
P. Woodard and W. Leung
PLATELETS, HAEMOSTASIS AND THROMBOSIS
Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous
factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in
heterozygous FII single gene mutation alone
M.-M. Samama, R. A. Rached, M.-H. Horellou, S. Aquilanti, V. G. Mathieux,
G. Plu-Bureau, I. Elalamy and J. Conard
A multicentre assessment of the endogenous thrombin potential using a
continuous monitoring amidolytic technique
A. S. Lawrie, E. Gray, D. Leeming, S. J. Davidson, G. Purdy, R. lampietro, S. Craig,
P. Rigsby and I. J. Mackie
Short report Two novel factor V null mutations associated with activated protein C resistance
phenotype/genotype discrepancy
Y. Dargaud, M. C. Trzeciak, S. Meunier, C. Angei, D. Pellechia, C. Négrier and
C. Vinciguerra
RED CELLS AND IRON
Familial polycythemia vera with Budd—Chiari syndrome in childhood
H. Cario, H. L. Pahl, K. Schwarz, C. Galm, M. Hoffmann, M. Burdelski, E. Kohne and
K.-M. Debatin
Heterocellular hereditary persistence of fetal haemoglobin affects the haematological
parameters of B-thalassaemia trait
C. Garner, T. K. Dew, R. Sherwood, D. Rees and S. L. Thein
viii Volume Contents
Causes of death in sickle cell disease: an autopsy study
E. A. Manci, D. E. Culberson, Y.-M. Yang, T. M. Gardner, R. Powell, J. Haynes Jr,
A. K. Shah and V. N. Mankad and Investigators of the Cooperative Study of Sickle Cell
Disease
CORRESPONDENCE
Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: treatment
outcomes with imatinib mesylate
R. A. Mesa, D. P. Steensma, J. Hoyer and R. P. Ketterling
Severe acute respiratory syndrome and lupus anticoagulants in children
E. Y. Chow and W. K. Chiu
Malignancies in sickle cell disease patients treated with hydroxyurea
A. Ferster, E. Sariban and N. Meuleman for the Belgian Registry of Sickle Cell Disease
patients treated with Hydroxyurea
Lithium effects on neutrophil motility in Shwachman—Diamond syndrome:
evaluation by computer-assisted image analysis
A. Azzara, G. Carulli and M. Petrini
Prognostic features of splenic lymphoma with villous lymphocytes
E. Iannitto, E. Ammatuna, A. M. Florena and V. Franco
Erythrocytosis and the Chuvash von Hippel-Lindau mutation
M. J. Percy, M. E. J. Beard, C. Carter and S. L. Thein
Endothelial cells express normal cellular prion protein
R. Starke, P. Harrison, R. Gale, I. Mackie, O. Drummond, I. MacGregor and S. Machin
Heparin-induced thrombocytopenia: pathogenesis and management
R. A. Saad
Heparin-induced thrombocytopenia: pathogenesis and management — Response to
Rasheed Saad
T. E. Warkentin
Volume 123, Issue 3, November-I 2003
IMAGES IN HAEMATOLOGY
Splenunculectomy in autoimmune thrombocytopenic purpura
P. A. Fields, H. Cohen and K. G. Patterson
Splenosis peritonei
S. Luminari, M. De Santis, A. Casolo and M. Federico
The reticulin stain in bone marrow biopsies — beyond marrow fibrosis
J. Ahluwalia, G. Garewal, R. Das and K. Vaiphei
REVIEW
Role of the microenvironment in chronic lymphocytic leukaemia
I’. Caligaris-Cappio
Volume Contents
HISTORICAL REVIEW
Louis Diamond and his contribution to haematology
W. C. Mentzer
HAEMATOLOGICAL MALIGNANCY
Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia
J. M. Chessells, P. Veys, H. Kempski, P. Henley, A. Leiper, D. Webb and I. M. Hann
Adult T-cell leukaemia/lymphoma-like human T-cell leukaemia virus-1 replication
in infective dermatitis
A.-S. Gabet, M. Kazanji, P. Couppie, E. Clity, J.-F. Pouliquen, D. Sainte-Marie, C. Aznar
and E. Wattel
Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid
leukaemia
J. Tiesmeier, A. Czwalinna, C. Muiiller-Tidow, J. Krauter, H. Serve, G. Heil, A. Ganser
and W. Verbeek
Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful
marker in both normal myelopoiesis and acute myeloid leukaemias
P. Virgo, P. A. Denning-Kendall, C. L. Erickson-Miller, S. Singha, R. Evely, J. M. Hows
and S. D. Freeman
Progenitor cell involvement is predictive of response to induction chemotherapy in
paediatric acute myeloid leukaemia
D. L. Johnston, S. Meshinchi, K. E. Opheim, M. G. Pallavicini, J. Feusner, W. G. Woods,
B. J. Lange, J. P. Radich and I. D. Bernstein
Single agent thalidomide in patients with relapsed or refractory acute myeloid
leukaemia
D. A. Thomas, E. Estey, F. J. Giles, S. Faderl, ]. Cortes, M. Keating, S. O’Brien, M. Albitar
and H. Kantarjian
Double Philadelphia masquerading as chromosome 20q deletion - a new
recurrent abnormality in chronic myeloid leukaemia blast crisis
A. G. Reid, S. Swanton, C. Grace, L. J. Campbell, A. R. Green and E. P. Nacheva
Together with the United Kingdom Cancer Cytogenetics Group (UKCCG)
HLA-DR4 predicts haematological response to cyclosporine in T-large granular
lymphocyte lymphoproliferative disorders
M. Battiwalla, J]. Melenhorst, Y. Saunthararajah, R. Nakamura, J]. Molldrem, N. S. Young
and A. J. Barrett
'SEDG positron emission tomography versus *7Ga scintigraphy as prognostic test
during chemotherapy for non-Hodgkin’s lymphoma
]. M. Zijlstra, O. S. Hoekstra, P. G. H. M. Raijmakers, E. F. I. Comans, J. J. M. van der
Hoeven, G. J. J. Teule, A. R. Jonkhoff, H. v Tinteren, A. A. Lammertsmanad P. C. Huijgens
The clinical impact of expert pathological review on lymphoma management: a
regional experience
]. F. Lester, S. D. Dojcinov, R. L. Attanoos, C. J. O'Brien, T. S. Maughan, E. T. Toy and
C. H. Poynton
Short reports Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid
leukaemia
M. Tischkowitz, N. Ameziane, Q. Waisfisz, J. P. De Winter, R. Harris, T. Taniguchi,
A. D'Andrea, S. V. Hodgson, C. G. Mathew and H. Joenje
The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow
cells and does not discriminate polycythaemia vera from reactive and other
chronic myeloproliferative disorders
O. Bock, E. Serinséz, M. Neusch, J. Schluée and H. Kreipe
Volume Contents
Frequent aberrant promoter hypermethylation of O°-methylguanine-DNA
methyltransferase and death-associated protein kinase genes in immunodefi-
ciency-related lymphomas
D. Rossi, G. Gaidano, A. Gloghini, C. Deambrogi, S. Franceschetti, E. Berra, M. Cerri,
C. Vendramin, A. Conconi, A. Viglio, G. Muti, P. Oreste, E. Morra, M. Paulli, D. Capello
and A. Carbone
TRANSPLANTATION
Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic
myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic
remission
M. W. Drummond, D. Marin, R. E. Clark, J. L. Byrne, T. L. Holyoake and A. Lennard on
behalf of the United Kingdom Chronic Myeloid Leukaemia (UK CML) Working Party
Survival after relapse following tandem autotransplants in multiple myeloma
patients: the University of Arkansas total therapy I experience
A. B.-T. Fassas, B. Barlogie, §. Ward, S. Jagannath, D. Vesole, S. Mattox, D. Siegel,
F. Muwalla, M. Zangari, E. Anaissie, F. V. Rhee, R. Thertulien, C.-K. Lee, R. Desikan,
V. Arzumanian, J. Mccoy and G. Tricot
PLATELETS, HAEMOSTASIS AND THROMBOSIS
Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with
venous thromboembolism without the antiphospholipid syndrome?
K. Hsieh, P. Knébl, C. Rintelen, P. A. Kyrle, P. Quehenberger, C. Bialonczyk, H. Partsch,
K. Lechner and I. Pabinger
Factor V 1359T: a novel mutation associated with thrombosis and resistance to
activated protein C
A. D. Mumford, J. H. McVey, C. V. Morse, K. Gomez, M. Steen, E. A. Norstrom,
E. G. D. Tuddenham, B. Dahlback and P. H. B. Bolton-Maggs
Long-term safety and feasibility of arteriovenous fistulae as vascular accesses in
children with haemophilia: a prospective study
E. Santagostino, A. Gringeri, L. Berardinelli, C. Beretta, M. Muca-Perja and
P. M. Mannucci
Central venous catheter related thrombosis in haematology patients and
prediction of risk by screening with Doppler-ultrasound
C. J. van Rooden, F. R. Rosendaal, R. M. Y. Barge, J. A. van Oostayen, F. J. M. van der
Meer, A. Edo Meinders and M. V. Huisman
Increased risk for vascular complications in PRV-1 positive patients with essential
thrombocythaemia
P. Johansson, A. Ricksten, L. Wennstrém, L. Palmqvist, J. Kutti and B. Andréasson
Long-term evaluation of 164 patients with essential thrombocythaemia treated
with pipobroman: occurrence of leukaemic evolution
V. De Sanctis, M. G. Mazzucconi, A. Spadea, M. Alfo, M. Mancini, L. Bizzoni, M.
Peraino and F. Mandelli
Endothelial cell activation in thrombotic thrombocytopenic purpura (TTP): a
prospective analysis
T. Romani de Wit, R. Fijnheer, H.-J. Brinkman, S. Kersting, R. J]. Hene and
J. A. van Mourik